Your Source for Venture Capital and Private Equity Financings

MycoWorks Raises $125M Series C Round

2022-01-13
EMERYVILLE, CA, Today, MycoWorks announced a $125 million Series C funding round.
The round was led by Prime Movers Lab, with participation from new investors SK Networks and Mirabaud Lifestyle Impact & Innovation Fund, in addition to other new and existing investors. The Series C funding round will be used to launch the first full-scale Fine Mycelium™ production plant to meet the growing demand for the company's materials, including MycoWorks' flagship product, Reishi™.

In 2013, co-founders Philip Ross and Sophia Wang formed MycoWorks, a San Francisco-based biomaterials company dedicated to bringing new mycelium materials to the world. MycoWorks' patented Fine Mycelium technology, an advanced manufacturing platform and breakthrough in materials science, engineers mycelium during growth to form proprietary, interlocking cellular structures for unparalleled strength and durability.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000 startups and 5,000 VC investors


Featured Reading